Aduro BioTech is an emerging leader in engineered immunotherapy technologies. The company’s proprietary platforms and therapeutic approaches have the potential to create transformative advances in cancer treatment. Headquartered in Berkeley, California, Aduro maintains close partnerships with outside organizations including Johns Hopkins University, Novartis Pharmaceuticals, and Providence Cancer Center.